Medicare Enrolled

Dr. Kathy Sam, M.D.

Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
7789 SOUTHWEST FWY STE 460, Houston, TX 77074
7137780300
In practice since 2008 (17 years)
NPI: 1427203819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sam

Dr. Kathy Sam is a hematology & oncology specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sam performed 32,899 Medicare services across 699 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sam received a total of $23,001 from 99 pharmaceutical and/or device companies across 1140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sam is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 28% volume in TX $23,001 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,899
Medicare services
Top 28% in TX for hematology & oncology
699
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,935 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 31,110 $0 $2
Complete blood count (CBC) with differential 706 $8 $24
Office visit, established patient (20-29 min) 271 $65 $280
Drug injection, under skin or into muscle 187 $11 $52
Administration of chemotherapy into vein, 1 hour or less 157 $100 $416
Office visit, established patient (30-39 min) 123 $97 $395
Office visit, established patient, complex (40-54 min) 95 $138 $559
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 74 $22 $91
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 70 $50 $205
Blood draw (venipuncture) 50 $8 $9
New patient office visit, complex (60-74 min) 39 $172 $678
New patient office visit (45-59 min) 17 $130 $515
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
95.0% high complexity
1.0% medium
4.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$23,001
Total received (2018-2024)
Avg $3,286/year across 7 years
Top 19% in TX for hematology & oncology
99
Companies
1,140
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,906 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$96 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,070
2023
$3,985
2022
$3,863
2021
$2,885
2020
$1,612
2019
$2,890
2018
$3,697

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,727
Novartis Pharmaceuticals Corporation
$1,565
AstraZeneca Pharmaceuticals LP
$1,539
Celgene Corporation
$1,324
Janssen Biotech, Inc.
$1,101
Merck Sharp & Dohme Corporation
$972
PFIZER INC.
$820
Merck Sharp & Dohme LLC
$816
Amgen Inc.
$731
Lilly USA, LLC
$644
GlaxoSmithKline, LLC.
$630
Genentech USA, Inc.
$599
Rigel Pharmaceuticals, Inc.
$529
GENZYME CORPORATION
$507
Incyte Corporation
$466
Boehringer Ingelheim Pharmaceuticals, Inc.
$401
BeiGene USA, Inc.
$390
Takeda Pharmaceuticals U.S.A., Inc.
$385
Seagen Inc.
$358
Eisai Inc.
$357
Teva Pharmaceuticals USA, Inc.
$297
Pharmacyclics LLC, An AbbVie Company
$285
Exelixis Inc.
$232
ARRAY BIOPHARMA INC
$218
Daiichi Sankyo Inc.
$214
Puma Biotechnology, Inc.
$211
JAZZ PHARMACEUTICALS INC.
$210
Regeneron Healthcare Solutions, Inc.
$209
Gilead Sciences, Inc.
$206
TerSera Therapeutics LLC
$193
Janssen Pharmaceuticals, Inc
$191
Pharmacyclics LLC, an AbbVie Company
$187
Adaptive Biotechnologies Corporation
$185
Stemline Therapeutics Inc.
$184
Myriad Genetic Laboratories, Inc.
$184
ABBVIE INC.
$183
Taiho Oncology, Inc.
$179
Foundation Medicine, Inc.
$177
Astellas Pharma US Inc
$155
Agios Pharmaceuticals, Inc.
$141
Biocompatibles, Inc.
$141
PUMA BIOTECHNOLOGY, INC.
$139
Bayer HealthCare Pharmaceuticals Inc.
$132
AbbVie Inc.
$127
MorphoSys, US Inc.
$127
Lexicon Pharmaceuticals, Inc.
$126
Alexion Pharmaceuticals, Inc.
$122
TESARO, Inc.
$115
Deciphera Pharmaceuticals Inc.
$106
Sirtex Medical Inc
$102
EISAI INC.
$101
Spectrum Pharmaceuticals Inc.
$98
Kite Pharma, Inc.
$97
PharmaEssentia USA Corporation
$92
Ipsen Biopharmaceuticals, Inc
$83
SpringWorks Therapeutics, Inc.
$80
Mirati Therapeutics, Inc.
$75
SERVIER PHARMACEUTICALS LLC
$67
Verastem, Inc.
$60
TAIHO ONCOLOGY, INC.
$56
ImmunoGen, Inc.
$52
Boston Scientific Corporation
$49
AVEO Pharmaceuticals, Inc.
$47
EMD Serono, Inc.
$45
CTI BioPharma Corp.
$45
Mylan Institutional Inc.
$45
Servier Pharmaceuticals LLC
$38
Clovis Oncology, Inc.
$38
Aveo Pharmaceuticals, Inc.
$37
Secura Bio, Inc.
$36
Iovance Biotherapeutics, Inc.
$33
SOBI, INC
$32
Fortovia Therapeutics, Inc.
$32
Dendreon Pharmaceuticals LLC
$32
Seattle Genetics, Inc.
$32
Dova Pharmaceuticals
$31
Bayer Healthcare Pharmaceuticals Inc.
$26
Acceleron Pharma, Inc.
$25
Immunomedics, Inc.
$25
AMAG Pharmaceuticals, Inc.
$25
Biocon Biologics Inc
$24
Kyowa Kirin, Inc.
$23
Sumitomo Pharma America, Inc.
$22
Pharmacosmos Therapeutics Inc.
$21
Array BioPharma Inc.
$20
Advanced Accelerator Applications
$19
Apellis Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$18
Jazz Pharmaceuticals Inc.
$18
Sysmex Inostics Inc
$18
Tempus AI, Inc
$17
Otsuka America Pharmaceutical, Inc.
$17
AbbVie, Inc.
$16
Verity Pharmaceuticals Inc.
$16
Stimwave Technologies Incorporated
$15
Acrotech Biopharma Inc.
$14
Octapharma USA, Inc.
$13
Mylan Pharmaceuticals Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$12
Top 3 companies account for 21.0% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Alecensa · Aliqopa · Amtagvi · Aranesp · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAXOTERE · TECENTRIQ · TECVAYLI · THERASPHERE - BIO · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · Truxima · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $70 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
196
Per 100K population
4.1
County median income
$73,104
Nearest hospital
WEST OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sam is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), with low-engagement industry engagement in the top 19% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sam experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sam performed 31,110 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sam receive payments from pharmaceutical companies?
Yes. Dr. Sam received a total of $23,001 from 99 companies across 1,140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sam's costs compare to other hematology & oncology specialists in Houston?
Dr. Sam's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →